Hongyun Zhao(赵洪云)

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou , China

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers149 papers

Sort

By YearBy Citation

Aurora kinases mediate resistance to PI3K inhibition in head and neck squamous cell carcinoma

V. Sambandam, T. Mazumdar,L. Shen,H. Zhao, S. Peng,J. Wang,F.M. Johnson

International Journal of Radiation Oncology Biology Physics, no. 5 (2020): 1184

Bibtex

Guidance for safely performing oncologic surgery during the COVID-19 pandemic

H. Zhao,S. Yan,F. Zhang,J. D. Wright,J. Y. Hou,J. P. Cata,X. Cai,D. Xiu,Y. Mao,B. Zhang,S. Du,M. Li

British Journal of Surgery, no. 10 (2020)

Bibtex

[The questions and suggestions of neurological intervention surgery therapy during the coronavirus disease 2019 pandemic]

X B Hu,X B Jiang, Z Y Xiong,Y Y Hu,C Y Liu,H Y Zhao

Zhonghua yi xue za zhi, no. 47 (2020): 3755-3758

WOSBibtex

[Comparison of Three CNN Models Applied in Bone Age Assessment of Pelvic Radiographs of Adolescents]

L Q Peng,L Wan,M W Wang,Z Li, P Wang, T A Liu,Y H Wang,H Zhao

Fa yi xue za zhi, no. 5 (2020): 622-630

WOSBibtex

Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study

Shen Zhao,Zhen Zhang,Wenfeng Fang,Yaxiong Zhang, Zhonghan Zhang,Shaodong Hong,Yuxiang Ma,Ting Zhou,Yunpeng Yang,Yan Huang,Hongyun Zhao,Li Zhang

Frontiers in oncology, (2020): 587849

WOSBibtex

Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma

Chen Chen, Yixin Zhou, Xuanye Zhang, Sha Fu, Zuan Lin,Wenfeng Fang,Yunpeng Yang,Yan Huang,Hongyun Zhao,Shaodong Hong,Li Zhang

Cancer medicine, (2020)

WOSBibtex

[Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version)]

Caicun Zhou,Jie Wang,Hong Bu, Baocheng Wang,Baohui Han,You Lu,Zhehai Wang, Bo Zhu,Ziping Wang,Qibin Song,Shengxiang Ren,Dongmei Lin

Zhongguo fei ai za zhi = Chinese journal of lung cancer, no. 2 (2020): 65-76

WOSBibtex

A phase Ib study of a novel c-MET, AXL and VEGFR-2 inhibitor ningetinib and gefitinib combination therapy in Chinese EGFR-TKI resistant NSCLC with T790M negative

Hongyun Zhao, Lianke Liu,Yuxiang Ma,Jian Fang,Wenfeng Fang, Haiqing Ma,Yang Zhang, Guosheng Feng,Shaodong Hong,Shan Zeng, Bo Xie,Jun Ren

Journal of Clinical Oncology, (2020): 9583-9583

Bibtex

Establishment and application of a predictive model for gefitinib-induced severe rash based on pharmacometabolomic profiling and polymorphisms of transporters in non-small cell lung cancer

Shaoxing Guan,Xi Chen,Shuang Xin, Shu Liu,Yunpeng Yang,Wenfeng Fang,Yan Huang,Hongyun Zhao,Xia Zhu,Wei Zhuang,Fei Wang,Wei Feng

Translational oncology, no. 1 (2020): 100951

WOSBibtex

Preliminary Exploration on Ideological and Political Teaching of Experimental Courses in Universities from the Perspective of Craftsman Spirit

Hai-Feng Yang, Wei-Jia Zhou,Li Zhou, Fa Liu,Hong-Yun Zhao

DEStech Transactions on Social Science, Education and Human Science, (2020)

Bibtex

Prognostic value of serum high-density lipoprotein cholesterol elevation in nonsmall cell lung cancer patients receiving radical surgery

Fan Luo, Kang‐mei Zeng, Zhong‐han Zhang,Ting Zhou,Jian‐hua Zhan, Fei‐teng Lu,Yun‐peng Yang,Yan Huang,Li Zhang,Hong‐yun Zhao

Clinical and translational medicine, (2020)

Bibtex

A phase I, dose-escalation and expansion study of TQ-B3139, a novel ALK TKI, in Chinese ALK or ROS1 positive advanced non-small cell lung cancer (NSCLC)

Yuxiang Ma,Nong Yang,Su Li,Hongyun Zhao,Liu Li, Haiyan Yang,Wenfeng Fang,Yang Zhang,Shaodong Hong,Yi Xiong, Chunhua Zhou, Yongchang Zhang

Journal of Clinical Oncology, (2020): 9585-9585

Bibtex

The preliminary efficacy and safety data of KN046 in patients failed on prior immune checkpoint inhibitors therapy

Hongyun Zhao,Yuxiang Ma,Yang Zhang,Shaodong Hong,Yunpeng Yang,Wenfeng Fang, June Xu, Hardy Van, Paul Kong, Fei Yang, Jingying Li, Yao Lu

Journal of Clinical Oncology, (2020): 3020-3020

Bibtex

Impact of prior cancer history on the overall survival of younger patients with lung cancer

Jiaqing Liu, Huaqiang Zhou,Yaxiong Zhang,Wenfeng Fang,Yunpeng Yang,Shaodong Hong,Gang Chen, Shen Zhao,Xi Chen, Zhonghan Zhang, Wei Xian, Jiayi Shen

ESMO open, no. 1 (2020)

WOSBibtex

Phase Ia dose escalation of IBI318, a first-in-class bispecific anti-PD-1/PD-L1, in patients with advanced tumors

Rui-hua Xu,Hongyun Zhao,Xiao-Li Wei,Yang Zhang,Feng Wang,Zhiqiang Wang,Fenghua Wang,Yu-Hong Li, Ben-Yan Zou, Xiaomin Zhu, Wencheng Yu, Hui Zhou

Journal of Clinical Oncology, (2020): 3062-3062

Bibtex

Histological analysis of socket preservation using DBBM. A systematic review and meta-analysis

H. Zhao,J. Hu,L. Zhao

Journal of Stomatology, Oral and Maxillofacial Surgery, (2020)

Bibtex

A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid Tumors

Jennifer Sheng,Li Zhang,Yuxiang Ma,Wenfeng Fang,Hongyun Zhao, Sai Praneeth Bathena, Amol Tendolkar

The oncologist, (2020)

WOSBibtex

[Experimental study on the effect of olfactory training on olfactory function in mice with olfactory dysfunction]

J H Zhou,D Xing,H M Ma,Y Zhao,Y H Zhao, H Q Wei

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck..., no. 2 (2020): 154-158

WOSBibtex

Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis

Ting Zhou, Zhonghan Zhang, Fan Luo,Yuanyuan Zhao,Xue Hou, Tingting Liu,Kai Wang,Hongyun Zhao,Yan Huang,Li Zhang

JAMA network open, no. 10 (2020)

WOSBibtex

View All

Base Info Papers Patents Projects